12936 Results

People

  1. Weigelt
    Weigelt
  2. Reis-Filho
    Reis-Filho
  3. Gonen
    Gonen
  4. Ladanyi
    Ladanyi
  5. Berger
    Berger
  6. Deasy
    Deasy
  7. Solit
    Solit
  8. Lewis
    Lewis
  9. Schultz
    Schultz
  10. De Stanchina
    De Stanchina

Groups

  1. Sloan Kettering Institute Postdocs (12936)
  2. GSK Faculty (6210)
  3. Department of Medicine (4656)
  4. Sloan Kettering Institute Faculty (3490)
  5. Surgery (2557)
  6. Solid Tumor Oncology Division (2525)
  7. Department of Pathology and Laboratory Medicine (2500)
  8. Center for Hematologic Malignancies (2324)
  9. Epidemiology and Biostatistics (1997)
  10. Human Oncology and Pathogenesis Program (1984)
  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (7820)
  2. Meeting Abstract (3612)
  3. Review (610)
  4. Editorial (251)
  5. Book Section (189)
  6. Conference Paper (160)
  7. Research Letter (133)
  8. Correspondence (63)
  9. Miscellaneous (62)
  10. Guidelines (30)
  11. Book Whole (6)
Groups
  1. Sloan Kettering Institute Postdocs (12936)
  2. GSK Faculty (6210)
  3. Department of Medicine (4656)
  4. Sloan Kettering Institute Faculty (3490)
  5. Surgery (2557)
  6. Solid Tumor Oncology Division (2525)

More Groups

People
  1. Britta Weigelt (366)
  2. Jorge Reis-Filho (327)
  3. Mithat Gonen (309)
  4. Marc Ladanyi (304)
  5. Joseph Deasy (278)
  6. Michael Berger (278)

More People

Years
  1. 2025 (394)
  2. 2024 (1038)
  3. 2023 (1151)
  4. 2022 (1364)
  5. 2021 (1176)
  6. 2020 (1240)

More Years

Publications
  1. Blood (641)
  2. Cancer Research (542)
  3. Journal of Clinical Oncology (416)
  4. Journal of Nuclear Medicine (261)
  5. Annals of Surgical Oncology (257)
  6. Clinical Cancer Research (235)

More Publications

Publishers
  1. Nature Publishing Group (1308)
  2. Elsevier Inc. (1173)
  3. American Association for Cancer Research (1039)
  4. Springer (818)
  5. Cell Press (719)
  6. American Society of Hematology (697)

More Publishers

Results (12936)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comment on "RAS/TP53 co-mutation is associated with worse survival after concurrent resection of colorectal liver metastases and extrahepatic disease"
    Correspondence

    Wang, J.; Andreatos, N.; Margonis, G. A.
    Annals of Surgery (2021)

    Fulltext@MSK | Save
  • An inducible genome engineering approach for preventing immune rejection of hESC-derived beta cells
    Meeting Abstract

    Sackett, S. D.; Mitchell, S. A.; Quirini, N.; Soh, C. L.; Caspi, I.; Mikat, A.; Huangfu, D.; Odorico, J.
    Transplantation (2021)

    Fulltext@MSK | Save
  • Risk index: A rational alternative to effective dose for procedure optimization
    Meeting Abstract

    Ocampo Ramos, J.; Carter, L.; Kesner, A.; Zanzonico, P.; Brown, J.; Bolch, W.
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save
  • (227)Th labeled 3,4,3-(LI-1,2-HOPO): Optimized synthesis, biological distribution and dosimetry
    Meeting Abstract

    Sanders, V.; Pratt, E.; Dinesh Bhupathiraju, N. V. S.; Carter, L.; Ferdous, J.; Marquez-Nostra, B.; Schlyer, D.; Lewis, J.; Francesconi, L.; Cutler, C.
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save
  • Comparative evaluation of the new MIRDcalc dosimetry software across a compendium of radiopharmaceuticals
    Meeting Abstract

    Carter, L.; Ocampo Ramos, J.; Zanzonico, P.; Bolch, W.; Kesner, A.
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save
  • Blood based genomic assessment of the clinical efficacy and toxicity of peptide receptor radionuclide therapy (PRRT)
    Meeting Abstract

    Bodei, L.; Raj, N.; Do, R. K. G.; Krebs, S.; Reidy, D.; Kidd, M.; Drozdov, I.; Modlin, I.; Schoder, H.
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save
  • LSD1 inhibition restores MHC class I expression and augments the anti-tumor response of immune checkpoint blockade in small cell lung cancer
    Meeting Abstract

    Sen, T.; Nguyen, M. N.; Taniguchi, H.; Chow, A.; De Stanchina, E.; Rudin, C. M.
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Promoting functional persistence in solid tumor CAR T-cell therapy: Mesothelin-targeted CAR (M28z1XXPD1DNR) with T-cell intrinsic PD1 dominant negative receptor
    Meeting Abstract

    Adusumilli, P. S.; Amador, A. M.; Chintala, N.; Hou, Z.; Offin, M.; Pineda, J.; Senechal, B.; Quach, H. T.; Bellis, R.; Banerjee, S.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Combining a CAR and a chimeric costimulatory receptor enhances T cell sensitivity to low antigen density and promotes persistence
    Journal Article

    Katsarou, A.; Sjöstrand, M.; Naik, J.; Mansilla-Soto, J.; Kefala, D.; Kladis, G.; Nianias, A.; Ruiter, R.; Poels, R.; Sarkar, I.; more...
    Science Translational Medicine (2021)

    Fulltext@MSK | Save
  • Incorporation of bacterial immunoevasins to protect cell therapies from host antibody-mediated immune rejection
    Journal Article

    Peraro, L.; Bourne, C. M.; Dacek, M. M.; Akalin, E.; Park, J. H.; Smith, E. L.; Scheinberg, D. A.
    Molecular Therapy (2021)

    Fulltext@MSK | Save